PNPLA3 and hepatocellular carcinoma: A recent study has demonstrated a better prediction of HCC risk when using genetic risk scores combining the PNPLA3, TM6SF2, glucokinase regulator (GCKR), MBOAT7, and 17β-hydroxysteroid dehydrogenase 13 (HSD17B13) variants [101].